Company / EPS (Basic)
MAIA Biotechnology, Inc. EPS (Basic) History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$1.49
FY2024
5-year range
-$2.37 / -$1.49
FY2022-FY2024
Trend
+14.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-2.37 to $-1.49 over the past 2 years.
Based on SEC 10-K filings.
-1.49 in FY2024.
Improved from $-2.37 to $-1.49 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, eps (basic) increased 14.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -11.78 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.49 | +14.9% |
| FY2023 | -$1.75 | +26.2% |
| FY2022 | -$2.37 | - |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 24, 2026